Companies House true 2025-07-01 2025-10-31 false 10799924 uk-bus:Director1 2025-07-01 2025-10-31 10799924 uk-bus:Director2 2025-07-01 2025-10-31 10799924 2025-07-01 2025-10-31 10799924 2025-10-31 10799924 uk-bus:EntityHasNeverTraded 2025-07-01 2025-10-31 10799924 uk-bus:FRS102 2025-07-01 2025-10-31 10799924 uk-bus:FullAccounts 2025-07-01 2025-10-31 10799924 uk-bus:AuditExempt-NoAccountantsReport 2025-07-01 2025-10-31 10799924 2025-06-30 10799924 uk-bus:OrdinaryShareClass1 2025-07-01 2025-10-31 10799924 uk-bus:OrdinaryShareClass2 2025-07-01 2025-10-31 10799924 uk-bus:OrdinaryShareClass3 2025-07-01 2025-10-31 10799924 uk-bus:PreferenceShareClass1 2025-07-01 2025-10-31 10799924 uk-bus:PreferenceShareClass2 2025-07-01 2025-10-31 10799924 uk-bus:PreferenceShareClass3 2025-07-01 2025-10-31 10799924 uk-core:ShareCapitalPreferenceShares 2025-10-31 10799924 uk-core:ShareCapitalPreferenceShares 2025-06-30 iso4217:GBP iso4217:GBP xbrli:shares xbrli:shares

Registered Number 10799924

ELITE HEALTH & HUMAN PERFORMANCE LIMITED

Dormant Accounts

31 October 2025

ELITE HEALTH & HUMAN PERFORMANCE LIMITED Registered Number 10799924

Balance Sheet as at 31 October 2025

31/10/2025 30/06/2025
£ £
Current assets
Cash at bank and in hand
20
20
Net assets
20
20
Issued share capital
10 Ordinary A Shares of £ 1 each 10 10
10 Ordinary B Shares of £ 1 each 10 10
Total Shareholder funds
20
20

STATEMENTS

  1. For the year ending 31 October 2025 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
  2. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  4. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 3 November 2025

And signed on their behalf by:
Daniel Jacobs, Director